{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T04:12:41Z","timestamp":1772856761110,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.urology.2009.12.010","type":"journal-article","created":{"date-parts":[[2010,3,8]],"date-time":"2010-03-08T02:38:57Z","timestamp":1268015937000},"page":"1144-1148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Efficacy and Safety of Tolterodine Extended Release and Dutasteride in Male Overactive Bladder Patients With Prostates >30 Grams"],"prefix":"10.1016","volume":"75","author":[{"given":"Doreen E.","family":"Chung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis E.","family":"Te","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Staskin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven A.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2009.12.010_bib1","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","article-title":"Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study","volume":"50","author":"Irwin","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2009.12.010_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1464-410X.2009.08369.x","article-title":"The overlap of storage, voiding and postmicturition symptoms and implications for treatment seeking in the USA, UK and Sweden: EpiLUTS","volume":"103","author":"Sexton","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2009.12.010_bib3","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0022-5347(05)65982-4","article-title":"Detrusor instability in men: correlation of lower urinary tract symptoms with urodynamic findings","volume":"166","author":"Hyman","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2009.12.010_bib4","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/j.1464-410X.2004.05158.x","article-title":"Serum prostate specific antigen to predict the presence of bladder outlet obstruction in men with urinary symptoms","volume":"94","author":"Laniado","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2009.12.010_bib5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0090-4295(02)02243-4","article-title":"The standardization of terminology in lower urinary tract function: report from the standardization sub-committee of the International Continence Society","volume":"61","author":"Abrams","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.urology.2009.12.010_bib6","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11934-002-0095-3","article-title":"Overactive bladder in the male patient: bladder, outlet, or both?","volume":"3","author":"Abdel-Aziz","year":"2002","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.urology.2009.12.010_bib7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0090-4295(97)00587-6","article-title":"A neurologic basis for the overactive bladder","volume":"50","author":"de Groat","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.urology.2009.12.010_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1464-410X.1994.tb07447.x","article-title":"The unstable bladder: towards a common mechanism","volume":"73","author":"Brading","year":"1994","journal-title":"Br J Urol"},{"key":"10.1016\/j.urology.2009.12.010_bib9","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0140-6736(01)05549-0","article-title":"Model of peripheral autonomous modules and a myovesical plexus in normal and overactive bladder function","volume":"358","author":"Drake","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.urology.2009.12.010_bib10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1464-410X.2006.06574.x","article-title":"The role of anticholinergics in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysis","volume":"99","author":"Blake-James","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2009.12.010_bib11","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.eururo.2006.02.018","article-title":"A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder","volume":"49","author":"Chapple","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2009.12.010_bib12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/nau.1001","article-title":"BPH with coexisting overactive bladder dysfunction\u2014an everyday urological dilemma","volume":"20","author":"Knutson","year":"2001","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2009.12.010_bib13","series-title":"Guideline on the Management of Benign Prostatic Hypertrophy (BPH): AUA Clinical Guidelines","author":"Roehrborn","year":"2006"},{"key":"10.1016\/j.urology.2009.12.010_bib14","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1464-410X.2004.05022.x","article-title":"Pharmacological therapy of benign prostatic hyperplasia\/lower urinary tract symptoms: an overview for the practising clinician","volume":"94","author":"Chapple","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2009.12.010_bib15","series-title":"Campbell's Urology","article-title":"Neuromuscular dysfunction of the lower urinary tract","author":"McGuire","year":"1986"},{"key":"10.1016\/j.urology.2009.12.010_bib16","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1001\/jama.296.19.2319","article-title":"Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial","volume":"296","author":"Kaplan","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2009.12.010_bib17","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/j.juro.2008.03.142","article-title":"Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia","volume":"179","author":"Kaplan","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2009.12.010_bib18","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0022-5347(05)00483-0","article-title":"Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction","volume":"175","author":"Abrams","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2009.12.010_bib19","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1464-410X.2004.05039.x","article-title":"Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder","volume":"94","author":"Lee","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2009.12.010_bib20","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.eururo.2008.06.032","article-title":"Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effect of prostate size","volume":"55","author":"Roehrborn","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2009.12.010_bib21","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.urology.2008.06.067","article-title":"Effects of serum PSA on efficacy of tolterodine extended release with or without tamsulosin in men with LUTS, including OAB","volume":"72","author":"Roehrborn","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.urology.2009.12.010_bib22","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.eururo.2006.01.007","article-title":"The validation of the patient perception of bladder condition (PPBC): a single-item global measure for patients with overactive bladder","volume":"49","author":"Coyne","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2009.12.010_bib23","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.eururo.2009.02.026","article-title":"Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder","volume":"56","author":"Irwin","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2009.12.010_bib24","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1111\/j.1464-410X.2008.07601.x","article-title":"The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study","volume":"101","author":"Coyne","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2009.12.010_bib25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1464-410X.1996.88213.x","article-title":"The effect of prostatectomy on symptom severity and quality of life","volume":"77","author":"Emberton","year":"1996","journal-title":"Br J Urol"},{"key":"10.1016\/j.urology.2009.12.010_bib26","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s11934-008-0050-z","article-title":"Persistent detrusor overactivity after transurethral resection of the prostate","volume":"9","author":"Housami","year":"2008","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.urology.2009.12.010_bib27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/01.ju.0000069827.09120.79","article-title":"Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the department of veterans affairs cooperative study trial","volume":"170","author":"Johnson","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2009.12.010_bib28","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.eururo.2008.11.026","article-title":"Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with alpha-blockers","volume":"56","author":"Chapple","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2009.12.010_bib29","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0022-5347(05)64688-5","article-title":"Correlations of urodynamic changes with changes in symptoms and well-being after transurethral resection of the prostate","volume":"168","author":"Van Venrooij","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2009.12.010_bib30","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.4065\/83.9.1002","article-title":"Efficacy and safety of extended-release oxybutynin in combination with tamsulosin for treatment of lower urinary tract symptoms in men: randomized double-blind placebo-controlled study","volume":"83","author":"MacDiarmid","year":"2008","journal-title":"Mayo Clin Proc"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429509030702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429509030702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:54:07Z","timestamp":1758765247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429509030702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0090429509030702"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2009.12.010","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Tolterodine Extended Release and Dutasteride in Male Overactive Bladder Patients With Prostates >30 Grams","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2009.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}